Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmoplantar Psoriasis”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Post-approval studies (Phase 4)UnknownNCT04622033
What this trial is testing

Brodalumab in Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
First OC Dermatology 10
Post-approval studies (Phase 4)Ended earlyNCT05710185
What this trial is testing

Deucravacitinib for the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Brigham and Women's Hospital 3
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Post-approval studies (Phase 4)Ended earlyNCT06042920
What this trial is testing

Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Who this might be right for
Palmoplantar PsoriasisGenital Psoriasis
Bristol-Myers Squibb 130
Post-approval studies (Phase 4)Study completedNCT04720105
What this trial is testing

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Who this might be right for
Palmoplantar PsoriasisPlaque Psoriasis
Icahn School of Medicine at Mount Sinai 22
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT03998683
What this trial is testing

Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag Ltd. 117
Large-scale testing (Phase 3)Study completedNCT04061252
What this trial is testing

KHK4827 in Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Kyowa Kirin Co., Ltd. 126
Not applicableLooking for participantsNCT07270003
What this trial is testing

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Xijing Hospital 60
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Testing effectiveness (Phase 2)Ended earlyNCT01197989
What this trial is testing

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Who this might be right for
Pustulosis of Palms and Soles
Lenzi Egisto S.P.A. 17
Not applicableLooking for participantsNCT04359394
What this trial is testing

International Rare And Severe Psoriasis Expert Network

Who this might be right for
Pustular Psoriasis (PP)
University Hospital, Basel, Switzerland 180
Large-scale testing (Phase 3)Study completedNCT00629772
What this trial is testing

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
Innovaderm Research Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01197976
What this trial is testing

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
Lenzi Egisto S.P.A. 20
Not applicableStudy completedNCT01780857
What this trial is testing

Immune Signature of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Baylor Research Institute 30
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT01806597
What this trial is testing

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Who this might be right for
Moderate to Severe Palmoplantar Psoriasis
Novartis Pharmaceuticals 205
Load More Results